Previous Close | 22.98 |
Open | 22.91 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 900 |
Day's Range | 22.50 - 23.39 |
52 Week Range | 15.58 - 78.58 |
Volume | |
Avg. Volume | 425,400 |
Market Cap | 604.263M |
Beta (5Y Monthly) | 1.11 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.04 |
Earnings Date | Aug 08, 2022 - Aug 12, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 48.29 |
FRIENDSWOOD, Texas, June 23, 2022--Castle announced findings from a study that evaluated uveal melanoma patients’ attitudes toward prognostic testing with DecisionDx-UM®.
FRIENDSWOOD, Texas, June 22, 2022--Castle shared new data regarding its skin cancer tests at the recent SDPA Annual Summer Dermatology Conference 2022.
FRIENDSWOOD, Texas, June 20, 2022--Castle Biosciences announced a new collaboration with Oregon Health & Science University's War on Melanoma™ public health campaign.